Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

AbbVie

Aurora Cannabis

CannTrust Holdings

GW Pharmaceuticals

Innovative Industrial Properties

Although recreational weed captures headlines, the real money is on broadly accepted medicinal marijuana stocks.

10 Medical Marijuana Stocks to Cure Your Portfolio

Accurately testing for THC levels is proving to be a big challenge for law enforcement.

1 Massive Problem for the Cannabis Industry That Needs to Be Addressed Immediately

Is there promise or peril on the horizon for one of the most popular pot stocks in the world?

5 Questions Cronos Group Must Answer With Its Third-Quarter Report

Investors will focus on Cronos' (CRON) regular top and bottom-line numbers along with its pipeline progress, when it reports Q3 results.

Cronos (CRON) to Report Q3 Earnings: What's in the Cards?

Should investors think about buying some shares of Cronos (CRON) ahead of earnings, as a bet on a marijuana market comeback?

Buy Cronos (CRON) Stock Ahead of Earnings as Bet on Marijuana Comeback?

Like many other high quality pot stocks, CRON stock will eventually rebound from this sell-off, but not here, and not now. 
The post Cronos Stock Will Eventually Rebound, but Not Anytime Soon appeared first on InvestorPlace.

Cronos Stock Will Eventually Rebound, but Not Anytime Soon

The company's Australian medical cannabis asset has polished off its IPO.

Cronos Group Just Took a Big Leap Overseas

Canopy Growth

Plenty of excitement could be on the way this month for these three pot stocks.

3 Top Marijuana Stocks to Watch in November

HEXO Corp

These popular pot stocks should remain off-limits this month.

3 Marijuana Stocks to Avoid Like the Plague in November

Altria

Altria Group Inc. MO, -0.81% Chief Financial Officer Billy Gifford said the tobacco company is happy with its investment in Canadian cannabis company Cronos Group Inc.

Altria CFO says Canadian cannabis company Cronos on track with deal that gives it foothold in U.S CBD market

Cronos stock is severely overvalued and is likely to fall further. Cronos is more expensive than any other Canadian cannabis stock, even despite the recent Altria investment
The post Don’t Count on Altria to Keep the Price of Cronos Stock Propped Up appeared first on InvestorPlace.

Don’t Count on Altria to Keep the Price of Cronos Stock Propped Up

As I add more cannabis and cannabis related firms to coverage, I’ve come across one that looks particularly unattractive.

Cronos Group’s Stock Is Way Too High

Aphria

Cowen

Hain Celestial Group

Constellation Brands

One key metric is exploding. It’s not the right one.

This One Chart Shows Why You Should Avoid Canadian Cannabis Stocks Like the Plague

TORONTO, Oct.  25, 2019  (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today noted the separately announced closing of the AUD$20 million initial public offering of Cronos Australia Limited (“Cronos Australia”). Under the offering, Cronos Australia issued 40 million new shares at an offering price of AUD$0.50 per share (the “Cronos Australia IPO”). Cronos Australia expects to start trading on the Australian Securities Exchange on a deferred settlement basis on November 7, 2019.

Cronos Group Issues Statement on Separately Announced Closing of the IPO of Cronos Australia

Intel

Tesla

Options trading was hot in Intel, Tesla and Cronos Group stocks on Thursday. Here’s what the data suggests moving forward.

Friday’s Vital Data: Intel, Tesla and Cronos Group

The best stocks in the pot sector might be the medical marijuana plays. These 3 medical marijuana stocks should have big upside.

Three Medical Marijuana Stocks to Buy.

CRON stock is not for the faint of heart. Do you think you have what it takes to profit from this pot powerhouse?

Investors Should Jump Into Cronos Group Stock’s Mystery Moves

Scott Gottlieb's controversial proposal would be a mixed blessing for the U.S. cannabis industry.

The Federal Government Should Regulate State Marijuana Programs, Former FDA Head Advocates

Canadian cannabis producer Cronos Group is "a new king in the north," an analyst said in upgrading the stock.
The post Why An Analyst Calls This Cannabis Stock The 'New King In The North' appeared first on Investor's Business Daily.

Why An Analyst Calls This Cannabis Stock The 'New King In The North'

Disney

Netflix

Options trading was buzzing in Cronos Group, Netflix and Disney on Thursday. Here are the metrics that matter moving forward.

Friday’s Vital Data: Cronos Group, Netflix and Disney

Alcoa

Limelight Networks

Earnings season continued to lift many stocks.

Why Cronos Group, Limelight Networks, and Alcoa Jumped Today

Cronos Group Inc. (NASDAQ: CRON) shares spiked 41.5% during Wednesday's after-market session at about 6:20 p.m.

Cronos Group's 40% After-Hours Mystery Rally: What We Know

Cronos Australia could help lend some credibility to Cronos Group, but it appears too small to significantly affect CRON stock.
The post Cronos Australia Offers Little Help to Cronos Group Stock appeared first on InvestorPlace.

Cronos Australia Offers Little Help to Cronos Group Stock

OrganiGram Holdings Inc.

Tilray Brands

The beaten-down pot industry is getting much-needed relief from Cannabis 2.0.

Here's Why Pot Stocks Are Surging Today

Shares of Cronos Group Inc. CRON, +0.96% CRON, +0.27% rampaged in the extended session Wednesday, gaining as much as 41.5% as of 6:22 p.m.

News for Cronos Group Stock (CRON)